SCHEMBL4599690

SCHEMBL4599690

COc1ccc(CNc2[c]ccc(Cl)c2)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.54
TSHR P16473 7/20 0.45
CYP1A2 P05177 6/20 0.45
CYP3A4 P08684 6/20 0.45
CYP2D6 P10635 6/20 0.45
CYP2C19 P33261 6/20 0.45
CLK4 Q9HAZ1 5/20 0.45
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 2/20 0.45
HSD17B10 Q99714 2/20 0.45
CYP2C9 P11712 1/20 0.45
HIF1A Q16665 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
LMNA P02545 3/20 0.44
GLA P06280 1/20 0.44
DHFR P00374 1/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599467 0.84 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4599436 0.84 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4598985 0.81 HTT (0.48) CLK4ALDH1A1MEN1KMT2ATDP1
SCHEMBL4710973 0.80 APLNR (0.51) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4600346 0.79 APLNR (0.48) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4599680 0.79 MAPT (0.52) APLNRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL4599421 0.77 MAOB (0.50) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL4610582 0.75 ALDH1A1 (0.45) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL27972158 0.74 APLNR (0.54) APLNRTSHRCYP1A2CYP3A4CYP2D6
SCHEMBL23852696 0.72 APLNR (0.59) APLNRTSHRCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed